NL-OMON20343招募中不适用
Fecal Immunochemical Testing as a Tool to Determine the Need for Colonoscopy in Symptomatic Patients
Erasmus MC (s-Gravendijkwal 230 3015 CE Rotterdam P.O. Box 2040, 3000 CA Rotterdam Phone: +31 10 704 0704) and Sysmex Europe (Postbus 251 4870 AG Etten-Leur Phone: +31(0)765086000)0 个研究点目标入组 807 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 807
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Referral for a diagnostic colonoscopy because of (new) bowel symptoms.
- •2. Able to undergo colonoscopy.
排除标准
- •Subjects will be excluded if they are referred for colonoscopy surveillance for other
- •indications (including hereditary CRC syndrome, familial CRC syndrome, inflammatory
- •bowel disease, history of colorectal adenoma or CRC)
研究者
相似试验
进行中（未招募）
Unknown
Implementation of mailed colon cancer screening testingCancerISRCTN22187559Minneapolis VA Health Care System9,000
招募中
不适用
Comparison study of two fecal immunochemical tests within a nationwide colorectal cancer screening programscreening, colorectal cancerNL-OMON26021Erasmus Medical Centre44,038
已完成
不适用
Two-sample FIT-screening: a 4th screening roundcolorectal cancer, screening, darmkankerNL-OMON20828Erasmus Medical Center3,197
Unknown
不适用
A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing ColonoscopyColon CancerNCT00533975University of California, San Diego500
招募中
不适用
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot study10017966colitisNL-OMON42995ederlands Kanker Instituut50